(Q28192692)

acute myocardial infarction

inferred from title

1 reference

Josep Darbà

1

0 references

Iñaki Izquierdo

2

0 references

Caridad Pontes

3

0 references

Carlos Navas

4

0 references

Joan Rovira

Treatment for acute myocardial infarction. Overview of randomized clinical trials

5

0 references

language of work or name

English

0 references

publication date

2002

0 references

published in

PharmacoEconomics

0 references

volume

20

0 references

issue

3

0 references

page(s)

195-201

0 references

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220030-00005

Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220030-00005

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220030-00005

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220030-00005

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220030-00005

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220030-00005

Randomized comparative trial of triflusal and aspirin following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220030-00005

Platelet count, antiplatelet therapy and pulmonary embolism--a prospective study in patients with hip surgery

21 January 2018

1 reference

12 December 2020

Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: results of a Spanish multicenter trial. Grupo de Estudio del Triflusal en la Angina Inestable

1 reference

12 December 2020

1 reference

12 December 2020

Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.

1 reference

12 December 2020

Cardiovascular mortality in Spain and its autonomous communities (1975-1992)

1 reference

12 December 2020

The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group

1 reference

12 December 2020

Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid

1 reference

12 December 2020

1 reference

12 December 2020

Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Triflusal versus acetylsalicylic acid: a double-blind study for the prophylaxis of deep vein thrombosis after hip surgery

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Triflusal in the treatment of patients with chronic peripheral arteriopathy: multicentre double-blind clinical study vs placebo

1 reference

12 December 2020